Phase II study with temozolomide and capecitabine for patients with refractory colorectal cancer

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2013
This article has no abstract
Epistemonikos ID: b1719464a7cd52915b4b282b6e37a64f00954c84
First added on: Jan 22, 2025